DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLOâ„¢, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This ...
DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced its participation in the Immunoglobulin National Society (IgNS) 12 th National Conference, which ...
For people living with primary immunodeficiency, immunoglobulin replacement therapy is a cornerstone of treatment. These therapies help replace missing antibodies and reduce the risk of serious or ...
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
The prescribed dosage for Hizentra (immune globulin subcutaneous [human]) may vary depending on an individual’s treatment plan. Other factors, including your specific diagnosis, body weight, and ...
In an effort to help improve patient lives, Advanced Infusion Care (AIC), a division of AIS Healthcare, has embarked on a joint study with Grifols, a leading global provider of essential ...
Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results